BioNexus Gene Lab (BGLC) Competitors $0.34 +0.01 (+2.45%) As of 01/13/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BGLC vs. TOI, CCM, PMD, MRAI, ATIP, BRTX, KDLY, OPGN, OTRK, and MGRXShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Oncology Institute (TOI), Concord Medical Services (CCM), Psychemedics (PMD), Marpai (MRAI), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), Kindly MD (KDLY), OpGen (OPGN), Ontrak (OTRK), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Oncology Institute Concord Medical Services Psychemedics Marpai ATI Physical Therapy BioRestorative Therapies Kindly MD OpGen Ontrak Mangoceuticals Oncology Institute (NASDAQ:TOI) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership. Do analysts recommend TOI or BGLC? Oncology Institute presently has a consensus target price of $2.50, indicating a potential upside of 702.05%. Given Oncology Institute's stronger consensus rating and higher probable upside, research analysts clearly believe Oncology Institute is more favorable than BioNexus Gene Lab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00BioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation & earnings, TOI or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than Oncology Institute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$324.24M0.07-$83.07M-$0.78-0.40BioNexus Gene Lab$9.26M0.65-$2.63MN/AN/A Which has more risk and volatility, TOI or BGLC? Oncology Institute has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 5.59, indicating that its share price is 459% more volatile than the S&P 500. Does the MarketBeat Community prefer TOI or BGLC? Oncology Institute received 4 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% BioNexus Gene LabN/AN/A Do insiders & institutionals have more ownership in TOI or BGLC? 36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 18.9% of BioNexus Gene Lab shares are held by institutional investors. 9.5% of Oncology Institute shares are held by insiders. Comparatively, 2.0% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is TOI or BGLC more profitable? BioNexus Gene Lab has a net margin of -10.17% compared to Oncology Institute's net margin of -17.63%. BioNexus Gene Lab's return on equity of -9.93% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% BioNexus Gene Lab -10.17%-9.93%-8.43% Does the media refer more to TOI or BGLC? In the previous week, Oncology Institute had 4 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 7 mentions for Oncology Institute and 3 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.16 beat Oncology Institute's score of 0.09 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Oncology Institute Neutral BioNexus Gene Lab Positive SummaryOncology Institute beats BioNexus Gene Lab on 8 of the 15 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.02M$2.99B$5.30B$8.81BDividend YieldN/A15.49%5.07%4.00%P/E RatioN/A15.6586.4016.81Price / Sales0.65242.751,120.26114.86Price / CashN/A459.6343.2437.79Price / Book0.615.165.104.88Net Income-$2.63M-$33.85M$122.01M$228.12M7 Day Performance-8.24%-6.85%-3.82%-4.40%1 Month Performance28.80%-6.32%0.09%-0.08%1 Year Performance-28.72%8.32%25.24%13.15% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.5814 of 5 stars$0.34+2.4%N/A-28.7%$6.02M$9.26M0.0030Short Interest ↑Positive NewsTOIOncology Institute2.6391 of 5 stars$0.32-1.5%$2.50+692.6%-84.9%$23.83M$378.93M-0.40660Short Interest ↑CCMConcord Medical Services0.6604 of 5 stars$4.68+4.0%N/A-55.3%$20.32M$471.70M0.00970Analyst ForecastShort Interest ↑Gap DownPMDPsychemedics1.3072 of 5 stars$2.67-1.8%N/A-22.4%$15.73M$22.10M-5.24140Gap DownHigh Trading VolumeMRAIMarpaiN/A$1.00+11.1%$6.00+500.1%-4.8%$13.74M$34.87M-0.38150Gap DownATIPATI Physical Therapy0.0801 of 5 stars$2.73+6.6%N/A-58.1%$12.04M$741.86M-0.155,600BRTXBioRestorative Therapies4.1281 of 5 stars$1.59+6.0%$18.00+1,032.1%-2.5%$11.00M$377,000.00-1.047Short Interest ↓Positive NewsGap UpKDLYKindly MDN/A$1.40-8.7%N/AN/A$8.35M$2.88M0.00N/AShort Interest ↓News CoverageOPGNOpGenN/A$0.93+23.3%N/A-80.2%$7.77M$2.67M0.00100Analyst ForecastNews CoverageGap UpOTRKOntrak2.875 of 5 stars$1.81-1.6%$45.00+2,386.2%-58.9%$7.64M$11.24M-0.17250Short Interest ↑High Trading VolumeMGRXMangoceuticals1.5926 of 5 stars$2.65+6.9%N/A-96.2%$6.59M$755,000.00-0.463Short Interest ↓Gap UpHigh Trading Volume Related Companies and Tools Related Companies TOI Alternatives CCM Alternatives PMD Alternatives MRAI Alternatives ATIP Alternatives BRTX Alternatives KDLY Alternatives OPGN Alternatives OTRK Alternatives MGRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGLC) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
